Last week, the UK announced a world first in sexual health programming: a vaccine that can protect against infection by gonorrhoea bacteria is to be made available in sexual health clinics across England, Scotland and Wales. Now comes the rollout – which will require avoiding the mistakes of the past to make sure it reaches those most in need.
The vaccine has offered hope for intervention in an otherwise concerning landscape of increasing numbers of cases of gonorrhoea infection demonstrating resistance to treatment by antibiotics and with infection rates at their highest since records began.
